4. metabolic evaluation recurrence preventionprevention. 4.1. general metabolic considerations patient work-up 4.1.1. evaluation patient risk stone passage, every patient assigned low- high-risk group (table 3.3) stone formation (figure 4.1). reliable stone analysis infrared spectroscopy x-ray diffraction basic metabolic evaluation mandatory stone formers. high-risk stone formers require specific metabolic evaluation. stone type deciding factor diagnostic tests. different stone types include: calcium oxalate;calcium phosphate;uric acid;ammonium urate;struvite (and infection stones);cystine;xanthine;2,8-dihydroxyadenine;drug stones;stones unknown composition. figure 4.1: assignment patients low- high-risk groups stone formation 4.1.2. urine sampling specific metabolic evaluation requires collection two consecutive 24-hour urine samples . collecting bottles prepared 1 g thymol per liter stored < 8°c collection reduce bacterial proliferation . pre-analytical errors minimised carrying urinalysis immediately collection. alternatively, boric acid (10 g powder per urine container) also used, prevents correct determination ph . collecting method chosen close cooperation laboratory. ph < 5.5 24-hour urine indicates hyper acidic urine (acidic arrest) [540-542]. course alkalinising therapy cystinuria uric acid stones, urine ph assessed collection freshly voided urine different times throughout day using sensitive ph dipsticks ph-meter . consensus statement stated rta suspected 24-hour urine ph > 6.2 fasting second-morning spot urine ph > 5.8 . spot urine samples alternative sampling method, particularly 24-hour urine collection difficult, example, non-toilet-trained children . spot urine studies normally link excretion rates creatinine , limited use results may vary collection time patients’ sex, body weight, age. 4.1.3. timing specific metabolic work-up initial specific metabolic work-up, patient stay self-determined diet normal daily conditions ideally stone-free least twenty days . follow-up studies necessary patients taking medication recurrence prevention . first follow-up 24-hour urine measurement suggested eight twelve weeks starting pharmacological prevention stone recurrence. enables diet and/or drug dosage adjusted urinary risk factors normalised, 24-hour urine measurements, necessary. urinary parameters normalised, sufficient perform 24-hour urine evaluation every twelve months. issue, panel realises limited published evidence. 4.1.4. reference ranges laboratory values tables 4.1-4.4 provide internationally accepted reference ranges different laboratory values serum urine. table 4.1: normal laboratory values blood parameters adults blood parameterreference rangecreatinine50-100 μmol/lsodium135-145 mmol/lpotassium3.5-5.5 mmol/lcalcium2.0-2.5 mmol/l (total calcium)1.12-1.32 mmol/l (ionised calcium)uric acid119-380 μmol/lchloride98-112 mmol/lphosphate0.81-1.29 mmol/lblood gas analysisph7.35-7.45po280-90 mmhgpco235-45 mmhghco322-26 mmol/lbebe ± 2 mmol/l = base excess (loss buffer base neutralise acid); hco = bicarbonate; pco = partial pressure carbon dioxide; po = partial pressure oxygen. 4.1.5. risk indices additional diagnostic tools several risk indices developed describe crystallisation risk calcium oxalate calcium phosphate urine [550-553]. however, clinical validation risk indices recurrence prediction therapy improvement ongoing. table 4.2: laboratory values urinary parameters adults urinary parametersreference ranges limits medical attentionphconsistently fasting morning spot urine ph > 5.8 > 6.2 24-hr collection (suspicious renal tubular acidosis) consistently > 7.0 (suspicious infection)consistently < 5.5 morning urine 24-hr collection (suspicious acidic arrest) specific weightspecific weight > 1.010creatinine7-13 mmol/day (females), 13-18 mmol/day (males)calcium> 5.0 mmol/day (see fig. 4.2)> 8.0 mmol/day (see fig. 4.2)oxalate> 0.5 mmol/day (suspicious enteric hyperoxaluria)>1.0 mmol/day (suspicious primary hyperoxaluria)uric acid> 4.0 mmol/day (females), 5 mmol/day (males)citrate< male < 1.7 mmol/day, female < 1.9 mmol/daymagnesium< 3.0 mmol/dayinorganic phosphate> 35 mmol/dayammonium> 50 mmol/daycystine> 0.8 mmol/day table 4.3: normal values spot urine samples: creatinine ratios (solute/creatinine) children parameter/patient ageratio solute creatinineunitscalciummol/molmg/mg< 12 months< 2.00.811-3 years< 1.50.531-5 years< 1.10.395-7 years< 0.80.28> 7 years< 0.60.21oxalatemol/molmg/mg0-6 months< 325-360288-2607-24 months< 132-174110-1392-5 years< 98-101805-14 years< 70-8260-65> 16 years< 4032citratemol/molg/g0-5 years> 0.250.42> 5 years> 0.150.25magnesium*mol/molg/g> 0.63> 0.13uric acid> 2 years< 0.56 mg/dl (33 μmol/l) per gfr (ratio x plasma creatinine) * low-level evidence regarding importance magnesium. table 4.4: solute excretion 24-hour urine samples children * calcium/24citrate/24 hourcystine/24 houroxalate/24 hoururate/24 hourall age groupsboysgirls< 10 years> 10 yearsall agegroups< 1 year1-5 years> 5 years< 0.1 mmol/kg/24 h> 1.9 mmol/1.73 m2/24 h> 1.6 mmol/1.73 m2/24 h< 55 μmol/1.73 m2/24 h< 200 μmol/1.73 m2/24 h< 0.5 mmol/1.73 m2/24 h< 70 μmol/kg/24 h< 65 mμmol/kg/24 h< 55 μmol/kg/24 h< 4 mg/kg/24 h> 365 mg/1.73 m2/24 h> 310 mg/1.73 m2/24 h< 13 mg/1.73 m2/24 h< 48 mg/1.73 m2/24 h< 45 mg /1.73 m2/24 h< 13 mg/kg/24 h< 11 mg/kg/24 h< 9.3 mg/kg/24 h *24 h urine parameters diet gender-dependent may vary geographically.